UW Infectious Disease Fellowship Program

@uwidfellowship.bsky.social

The very best of ID training and #IDSky, in Seattle WA.🦠🧫🏔️☀️☕️ Official account of the Univ of WA ID Fellowship Program | PD Meena Ramchandani & APD Fred Buckner Content: Chief fellows Alison Smith & Michael Dagher. Also on Instagram @uwidfellowship!

Sharing recent work from third-year fellow Brendan Mullen (co-first author!) on the performance of urine LAM for pediatric pulmonary TB diagnosis. And big congratulations to Brendan on his recent selection for a NIAID Clinical Research Loan Repayment award! 🎉 academic.oup.com/ofid/article...

P-1677. Nanoparticle Capture of Urinary Lipoarabinomannan for Diagnosing Childhood Tuberculosis

AbstractBackground. Non-respiratory biomarkers for tuberculosis (TB), such as the urinary lipoarabinomannan (LAM) antigen, are crucial for diagnosing TB in

academic.oup.com

“Revitalizing the NIH’s role in advancing science will require thoughtful and deliberate disruption, led by scientists and policymakers whose goal is to create the most impactful science” 📣📣📣 We’re proud of our faculty mentors for speaking up in this piece — academic.oup.com/jid/advance-...

Crisis as Catalyst: The future of the NIH driving scientific discovery

The National Institutes of Health (NIH) has an unparalleled record of advancing biomedical science. Today, two critical challenges threaten its future impa

academic.oup.com

New multi-center research by faculty Dr. Obeid, Dr. Young & colleagues highlights severe challenges in treating refractory HSV in stem cell transplant recipients. With high acyclovir resistance & drug toxicity, their findings stress the urgent need for safer, oral antivirals. #IDSky

Refractory Mucocutaneous Infections by Herpes Simplex Virus (HSV) in Hematopoietic Cell Transplant Recipients: A Real-world, Multicenter Study

A total of 55.2% HCT recipients with refractory HSV healed completely at a median of 38 days of therapy. Seventy-five percent of patients received foscarne

academic.oup.com

The acting director of the Center of Scientific Review (CSR) at NIH , Raymond Jacobson, PhD, has been appointed as the permanent director of CSR (staring Sunday). Good news as he is thoroughly familiar with NIH peer review.

An email from NIH Director Bhattacharya appointing Raymond Jacobson, PhD as Director of the Center of Scientific Review.